Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03845517
What this trial is testing

A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Pfizer 350
Not applicableNot Yet RecruitingNCT07805863
What this trial is testing

Serum MPO-DNA Complexes as a Biomarker of Disease Activity in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Assiut University 90
Not applicableStudy completedNCT04461158
What this trial is testing

CCCR Lupus Patient Navigator Program

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Medical University of South Carolina 75
Not applicableUnknownNCT06544343
What this trial is testing

Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisSystemic Lupus Erythematosus+3 more
University Of Perugia 190
Not applicableStudy completedNCT07481214
What this trial is testing

Lupus Walking Intervention to Address Fatigue/Quality of Life

Who this might be right for
System Lupus Erythematosus(SLE)
University of California, San Francisco 101
Testing effectiveness (Phase 2)Active Not RecruitingNCT06530849
What this trial is testing

GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus

Who this might be right for
Refractory Systemic Lupus Erythematosus
Gracell Biotechnologies (Shanghai) Co., Ltd. 20
Not applicableStudy completedNCT02456168
What this trial is testing

Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwell Health 30
Early research (Phase 1)WithdrawnNCT01018238
What this trial is testing

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
InflammationSystemic Lupus Erythematosus
Novo Nordisk A/S
Not applicableEnded earlyNCT04335747
What this trial is testing

COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+2 more
Salome Kristensen 53
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07221565
What this trial is testing

Electromagnetic Immunotherapy Mapping and Cytokine Forecasting Study (QSIT)

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisMultiple Sclerosis+3 more
Truway Health, Inc. 120
Testing effectiveness (Phase 2)UnknownNCT05465707
What this trial is testing

CM313 Injection in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Keymed Biosciences Co.Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01687192
What this trial is testing

Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

Who this might be right for
TransplantationSystemic Lupus ErythematosusSystemic Immune Disease
University Hospital, Bordeaux 37
Early research (Phase 1)Looking for participantsNCT06975787
What this trial is testing

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Regeneron Pharmaceuticals 90
Testing effectiveness (Phase 2)Study completedNCT00004643
What this trial is testing

Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Center for Research Resources (NCRR) 10
Testing effectiveness (Phase 2)Study completedNCT01305746
What this trial is testing

A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals 382
Early research (Phase 1)Not Yet RecruitingNCT07358988
What this trial is testing

KN5501 Cell Injection for Refractory SLE(CLEAR)

Who this might be right for
Systemic Lupus Erthematosus (SLE)
Ruitherapeutics Co., LTD 36
Not applicableUnknownNCT03728231
What this trial is testing

Disease Activity in RA and SLE Patients and Its Relation to Muscle Performance,Fatigue and Blood Parameters

Who this might be right for
Rheumatic Diseases
Assiut University 150
Testing effectiveness (Phase 2)Study completedNCT00583362
What this trial is testing

A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 298
Large-scale testing (Phase 3)Looking for participantsNCT06618573
What this trial is testing

Safety of Administering Isoniazid to SLE Patients to Prevent TB

Who this might be right for
TuberculosisSystemic Lupus Erythematosus
Universitas Padjadjaran 60
Not applicableStudy completedNCT04089930
What this trial is testing

Long-term Immunogenicity of a Live Herpes Zoster Vaccine in Systemic Lupus Erythematosus (SLE) Patients

Who this might be right for
Lupus Erythematosus
Tuen Mun Hospital 68
Next Page